This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Apr;17(4):589-92.

doi: 10.1161/01.hyp.17.4.589.

History of the design of captopril and related inhibitors of angiotensin converting enzyme

D W Cushman¹, M A Ondetti

Affiliations

PMID: 2013486
DOI: 10.1161/01.hyp.17.4.589

History of the design of captopril and related inhibitors of angiotensin converting enzyme

D W Cushman et al. Hypertension. 1991 Apr.

. 1991 Apr;17(4):589-92.

doi: 10.1161/01.hyp.17.4.589.

Authors

D W Cushman¹, M A Ondetti

Affiliation

¹ Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, N.J.

PMID: 2013486
DOI: 10.1161/01.hyp.17.4.589

No abstract available

PubMed Disclaimer

Similar articles

The discovery of captopril.
Smith CG, Vane JR. Smith CG, et al. FASEB J. 2003 May;17(8):788-9. doi: 10.1096/fj.03-0093life. FASEB J. 2003. PMID: 12724335 No abstract available.
The discovery of captopril: a reply.
Smith CG, Vane JR. Smith CG, et al. FASEB J. 2004 Jun;18(9):935. doi: 10.1096/fj.04-1992lte. FASEB J. 2004. PMID: 15173103 No abstract available.
History of heart failure.
Ventura HO. Ventura HO. Congest Heart Fail. 2008 Nov-Dec;14(6):329. doi: 10.1111/j.1751-7133.2008.00015.x. Congest Heart Fail. 2008. PMID: 19076858 No abstract available.
Angiotensin-converting enzyme inhibitors: are they all alike?
Case DB. Case DB. J Clin Hypertens. 1987 Sep;3(3):243-56. J Clin Hypertens. 1987. PMID: 2822859 Review.
Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ. Wyvratt MJ. Clin Physiol Biochem. 1988;6(3-4):217-29. Clin Physiol Biochem. 1988. PMID: 2849521 Review.

See all similar articles

Cited by

Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.
Kanasaki M, Nagai T, Kitada M, Koya D, Kanasaki K. Kanasaki M, et al. Fibrogenesis Tissue Repair. 2011 Nov 30;4:25. doi: 10.1186/1755-1536-4-25. Fibrogenesis Tissue Repair. 2011. PMID: 22126210 Free PMC article.
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates.
Pu L, Naderi M, Liu T, Wu HC, Mukhopadhyay S, Brylinski M. Pu L, et al. BMC Pharmacol Toxicol. 2019 Jan 8;20(1):2. doi: 10.1186/s40360-018-0282-6. BMC Pharmacol Toxicol. 2019. PMID: 30621790 Free PMC article.
Pore-Forming Proteins from Cnidarians and Arachnids as Potential Biotechnological Tools.
Rivera-de-Torre E, Palacios-Ortega J, Gavilanes JG, Martínez-Del-Pozo Á, García-Linares S. Rivera-de-Torre E, et al. Toxins (Basel). 2019 Jun 25;11(6):370. doi: 10.3390/toxins11060370. Toxins (Basel). 2019. PMID: 31242582 Free PMC article.
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.
Abu Hasan Z', Williams H, Ismail NM, Othman H, Cozier GE, Acharya KR, Isaac RE. Abu Hasan Z', et al. Sci Rep. 2017 Mar 27;7:45409. doi: 10.1038/srep45409. Sci Rep. 2017. PMID: 28345667 Free PMC article.
Bradykinin-Potentiating Activity of a Gamma-Irradiated Bioactive Fraction Isolated from Scorpion (Leiurus quinquestriatus) Venom in Rats with Doxorubicin-Induced Acute Cardiotoxicity: Favorable Modulation of Oxidative Stress and Inflammatory, Fibrogenic and Apoptotic Pathways.
Ahmed LA, Abdou FY, El Fiky AA, Shaaban EA, Ain-Shoka AA. Ahmed LA, et al. Cardiovasc Toxicol. 2021 Feb;21(2):127-141. doi: 10.1007/s12012-020-09602-5. Epub 2020 Aug 29. Cardiovasc Toxicol. 2021. PMID: 32860604

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database